Digital Locations (DLOC) 10-K31 Mar 142013 FY Annual reportFinancial data

Company Profile

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
Document And Entity Information (USD $)	Dec. 31, 2013	Mar. 24, 2014	Jun. 28, 2013
Document And Entity Information	'	'	'
Entity Registrant Name	'Carbon Sciences, Inc.,	'	'
Entity Central Index Key	'0001407878	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Amendment Flag	'false	'	'
Current Fiscal Year End Date	'--12-31	'	'
Is Entity a Well-known Seasoned Issuer?	'No	'	'
Is Entity a Voluntary Filer?	'No	'	'
Is Entity's Reporting Status Current?	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$315,200
Entity Common Stock, Shares Outstanding	'	109,856,687	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2013	'	'
Entity Incorporation, Date of Incorporation	25-Aug-06	'	'

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
CURRENT ASSETS:	'	'
Cash	$11,382	$14,257
Prepaid expenses	3,758	12,888
Total current assets	15,140	27,145
PROPERTY AND EQUIPMENT, NET	1,182	3,536
OTHER ASSETS - Patents	1,784	1,584
Total assets	18,106	32,265
CURRENT LIABILITIES:	'	'
Accounts payable	217,418	274,485
Accrued expenses and other current liabilities	11,137	16,244
Accrued interest, notes payable	64,340	22,408
Notes payable	'	5,000
Derivative liability	2,811,962	753,971
Convertible notes payable, net of beneficial conversion feature of $8,849 and $0, respectively	182,651	'
Convertible notes payable, net of discount of $226,445 and $644,520, respectively	492,904	86,182
Total current liabilities	3,780,412	1,158,290
STOCKHOLDERS' DEFICIT:	'	'
Preferred stock, $0.001 par value; 20,000,000 shares authorized, no shares issued and outstanding	'	'
Common stock, $0.001 par value; 1,000,000,000 shares authorized, 72,134,930 and 11,576,680 shares issued and outstanding	72,135	11,577
Additional paid-in capital	10,614,891	9,814,228
Deficit accumulated during the development stage	-14,449,332	-10,951,830
Total stockholders' deficit	-3,762,306	-1,126,025
Total liabilities and stockholders' deficit	$18,106	$32,265

BALANCE_SHEETS_Parenthetical

BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Statement of Financial Position	'	'
Preferred Stock, par or stated value	$0.00	$0.00
Preferred Stock, shares authorized	20,000,000	20,000,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, par or stated value	$0.00	$0.00
Common Stock, shares authorized	1,000,000,000	1,000,000,000
Common Stock, shares issued	72,134,930	11,576,680
Common Stock, shares outstanding	72,134,930	11,576,680
Convertible promissory notes discount	$226,445	$644,520
Convertible promissory notes, beneficial conversion feature	$8,849	$0

STATEMENTS_OF_OPERATIONS

STATEMENTS OF OPERATIONS (USD $)	12 Months Ended		88 Months Ended
STATEMENTS OF OPERATIONS (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Income Statement	'	'	'
REVENUE	'	'	'
OPERATING EXPENSES:	'	'	'
General and administrative	470,363	1,829,698	8,818,284
Research and development	439	139,706	1,245,808
Depreciation and amortization	2,354	23,394	111,774
Total operating expenses	473,156	1,992,798	10,175,866
LOSS FROM OPERATIONS	-473,156	-1,992,798	-10,175,866
OTHER INCOME (EXPENSE):	'	'	'
Interest income	'	'	39,521
Rental income	14,250	'	14,250
Loss on sale of asset	'	-74,078	-69,033
Loss on foreign exchange	'	'	-2,327
Impairment of intangible assets	'	-88,147	-88,147
Loss on settlement of debt	-25,195	-705	-25,900
Gain on forgiveness of debt	20,000	102,000	122,000
Incentive fees	'	-1,079,800	-1,079,800
Loss on change in derivative liability	-2,267,693	-73,259	-2,340,952
Penalties	'	-288	-382
Interest expense	-765,708	-66,083	-842,696
Total other income (expense)	-3,024,346	-1,280,360	-4,273,466
LOSS BEFORE INCOME TAXES	-3,497,502	-3,273,158	-14,449,332
PROVISION FOR INCOME TAXES	'	'	'
NET LOSS	($3,497,502)	($3,273,158)	($14,449,332)
NET LOSS PER SHARE, BASIC AND DILUTED	($0.13)	($0.30)	'
WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC AND DILUTED	27,969,047	10,772,767	'

STATEMENTS_OF_SHAREHOLDERS_EQU

STATEMENTS OF SHAREHOLDERS' EQUITY/(DEFICIT) (USD $)	Common stock	Additional Paid-in Capital	Stock Subscriptions Payable	Deficit Accumulated during the Development Stage	Total
Stockholders' Equity at Aug. 24, 2006	'	'	'	'	'
Issuance of common stock for cash, value	$3,211	$536,164	'	'	$539,375
Issuance of common stock for cash, shares	3,211,125	'	'	'	'
Net Loss	'	'	'	-413,641	-413,641
Stockholders' Equity at Dec. 31, 2006	3,211	536,164	'	-413,641	125,734
Shares, Outstanding at Dec. 31, 2006	3,211,125	'	'	'	'
Issuance of common stock for cash, value	448	1,807,052	'	'	1,807,500
Issuance of common stock for cash, shares	448,125	'	'	'	'
Issuance of common stock for services, value	50	222,150	'	'	222,200
Issuance of common stock for services, shares	49,300	'	'	'	'
Stock issuance cost	'	-265,200	'	'	-265,200
Net Loss	'	'	'	-878,679	-878,679
Stockholders' Equity at Dec. 31, 2007	3,709	2,300,166	'	-1,292,320	1,011,555
Shares, Outstanding at Dec. 31, 2007	3,708,550	'	'	'	'
Stock subscriptions payable	'	'	62,000	'	62,000
Net Loss	'	'	'	-1,041,721	-1,041,721
Stockholders' Equity at Dec. 31, 2008	3,709	2,300,166	62,000	-2,334,041	31,834
Shares, Outstanding at Dec. 31, 2008	3,708,550	'	'	'	'
Issuance of common stock for cash, value	575	1,020,075	'	'	745,000
Issuance of common stock for cash, shares	574,175	'	'	'	'
Issuance of common stock for services, value	43	175,995	'	'	176,038
Issuance of common stock for services, shares	44,009	'	'	'	'
Stock issuance cost	'	-51,038	'	'	-51,038
Stock subscriptions payable	'	'	362,775	'	362,775
Issuance of common stock for subscription payable, value	37	149,088	-149,125	'	'
Issuance of common stock for subscription payable, shares	37,281	'	'	'	'
Issuance of common stock for conversion of debt, value	70	264,930	'	'	265,000
Issuance of common stock for conversion of debt, shares	69,737	'	'	'	'
Net Loss	'	'	'	-1,180,558	-1,180,558
Stockholders' Equity at Dec. 31, 2009	4,434	3,859,216	'	-3,514,599	349,051
Shares, Outstanding at Dec. 31, 2009	4,433,752	'	'	'	'
Issuance of common stock for cash, value	686	825,314	'	'	826,000
Issuance of common stock for cash, shares	685,715	'	'	'	'
Stock compensation expense for stock options granted and fully vested	'	1,230,000	'	'	1,230,000
Net Loss	'	'	'	-2,302,583	-2,302,583
Stockholders' Equity at Dec. 31, 2010	5,120	5,914,530	'	-5,817,182	102,468
Shares, Outstanding at Dec. 31, 2010	5,120,229	'	'	'	'
Issuance of common stock for cash, value	1,141	1,480,859	'	'	1,482,000
Issuance of common stock for cash, shares	1,141,000	'	'	'	'
Cashless issuance of common stock warrants, value	3,334	-3,334	'	'	'
Cashless issuance of common stock warrants, shares	3,333,338	'	'	'	'
Stock compensation cost	'	217,761	'	'	217,761
Net Loss	'	'	'	-1,861,490	-1,861,490
Stockholders' Equity at Dec. 31, 2011	9,595	7,609,816	'	-7,678,672	-59,261
Shares, Outstanding at Dec. 31, 2011	9,594,567	'	'	'	'
Issuance of common stock for cash, value	475	252,600	'	'	253,075
Issuance of common stock for cash, shares	474,721	'	'	'	474,721
Cashless issuance of common stock warrants, value	424	-424	'	'	'
Cashless issuance of common stock warrants, shares	423,943	'	'	'	423,943
Issuance of common stock for services, value	193	165,807	'	'	166,000
Issuance of common stock for services, shares	192,857	'	'	'	192,857
Issuance of common stock for incentive fee, value	875	1,078,925	'	'	1,079,800
Issuance of common stock for incentive fee, shares	875,000	'	'	'	'
Issuance of common stock for acccounts payable, value	15	15,690	'	'	15,705
Issuance of common stock for acccounts payable, shares	15,592	'	'	'	15,592
Stock compensation cost	'	691,814	'	'	691,814
Net Loss	'	'	'	-3,273,158	-3,273,158
Stockholders' Equity at Dec. 31, 2012	11,578	9,814,227	'	-10,951,830	-1,126,025
Shares, Outstanding at Dec. 31, 2012	11,576,680	'	'	'	'
Contribution of note payable to capital	'	28,621	'	'	28,621
Contribution of accrued interest to capital	'	7,175	'	'	7,175
Beneficial conversion factor for convertible notes payable	'	123,380	'	'	123,380
Issuance of common stock pursuant to price protection agreement, value	593	-593	'	'	'
Issuance of common stock pursuant to price protection agreement, shares	592,780	'	'	'	592,780
Stock compensation cost	'	101,755	'	'	101,755
Issuance of common stock for conversion of debt, value	59,965	540,325	'	'	600,290
Issuance of common stock for conversion of debt, shares	59,965,470	'	'	'	'
Net Loss	'	'	'	-3,497,502	-3,497,502
Stockholders' Equity at Dec. 31, 2013	$72,135	$10,614,891	'	($14,449,332)	($3,762,306)
Shares, Outstanding at Dec. 31, 2013	72,134,930	'	'	'	'

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		88 Months Ended
STATEMENTS OF CASH FLOWS (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'	'
Net Loss	($3,497,502)	($3,273,158)	($14,449,332)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Depreciation and amortization	2,354	23,394	111,774
Stock compensation cost	101,755	691,814	2,241,330
Common stock issued for services	'	166,000	417,038
Common stock issued for incentive fees	'	1,079,800	1,079,800
Loss on sale of assets	'	74,078	69,033
Impairment of intangible assets	'	88,147	88,147
Loss on settlement of debt	25,195	705	25,900
Gain on forgiveness of debt	-20,000	-102,000	-122,000
Notes payable issued for services	66,150	'	66,150
Amortization of debt discount and beneficial conversion feature recorded to interest expense	694,795	44,942	739,737
Loss on change in derivative liability	2,267,693	73,259	2,340,952
Changes in assets and liabilities:	'	'	'
(Increase) decrease in prepaid expenses	9,130	4,831	-3,758
Increase (decrease) in:	'	'	'
Accounts payable	32,903	250,124	424,388
Accrued expenses and other current liabilities	61,472	268,627	344,576
NET CASH USED IN OPERATING ACTIVITIES	-256,055	-609,437	-6,626,265
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'	'
Patent expenditures	-200	-19,146	-89,931
Purchase of property and equipment	'	'	-206,489
Proceeds from the sale of assets	'	'	24,500
NET CASH USED IN INVESTING ACTIVITIES	-200	-19,146	-271,920
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'	'
Proceeds from notes payable	11,000	'	636,000
Proceeds from convertible notes payable	242,380	417,500	634,880
Advances from officer	'	'	113,000
Net proceeds from issuance of common stock	'	253,075	5,908,687
Repayment of advances and notes payable	'	-35,000	-383,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	253,380	635,575	6,909,567
NET INCREASE (DECREASE) IN CASH	-2,875	6,992	11,382
CASH, BEGINNING OF THE PERIOD	14,257	7,265	'
CASH, END OF THE PERIOD	$11,382	$14,257	$11,382

1_Organization_and_Line_of_Bus

1. Organization and Line of Business	12 Months Ended
1. Organization and Line of Business	Dec. 31, 2013
Notes	'
1. Organization and Line of Business	'
	1. ORGANIZATION AND LINE OF BUSINESS

	Organizational History

	The Company was incorporated in the State of Nevada on August 25, 2006 as Zingerang, Inc. On April 2, 2007, the Company changed its name to Carbon Sciences, Inc.

	Overview of Business

	The Company was initially in the business of offering real-time and interactive mobile communication services to businesses and consumers under the Zingerang trade name. The Company is now pursuing a new line of business. The Company is developing a technology to convert earth destroying carbon dioxide (CO2) into a useful form that will not contribute to green house gases. This technology is based on a patent filed by the Company and developed under the brand name GreenCarbon Technology. By eliminating harmful CO2 from human created sources, such as power plants and industrial factories, the technology will provide a partial solution to the problem of global warming. GreenCarbon Technology is initially targeted at electrical power plants. CO2 makes up nearly 80% of all greenhouse gases. More than a quarter of that CO2 comes from electrical power plants.

	Going Concern

	The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities, and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate any revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon, among other things, raising additional capital. Since it’s inception through December 31, 2013, the Company has obtained funds primarily from the issuance of common stock and debt. Management believes this funding will continue, and is continually seeking new investors. Management believes the existing shareholders and lenders and prospective new investors will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core of business.

2_Summary_of_Significant_Accou

2. Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Notes	'
2. Summary of Significant Accounting Policies	'
	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	This summary of significant accounting policies is presented to assist in understanding our financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

	Development Stage Activities and Operations
	The Company is in the development stage of its operations and has had no revenues. A development stage activity is one in which all efforts are devoted substantially to establishing a new business and even if planned principal operations have commenced, revenues are insignificant.


	Revenue Recognition
	We will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, we have had no revenues and are in the development stage.


	Cash and Cash Equivalent
	We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents.


	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, and the fair value of stock options. Actual results could differ from those estimates.


	Property and Equipment
	Property and equipment are stated at cost, and are depreciated using the straight line method over the following estimated useful lives:

	Computer equipment	3 Years
	Machinery and equipment	7 Years

	During the year ended December 31, 2012, we abandoned equipment in the amount of $155,837, and recognized a loss of $74,078. Depreciation expense for the years ended December 31, 2013 and 2012 was $2,354 and $23,394, respectively.


	Patents and Impairment of Long-Lived Assets
	Our intangible assets that have finite lives consist of patents, the cost of which is amortized over the estimated legal life of 15 years. During the year ended December 31, 2012, we reviewed the capitalized costs of patents for impairment and determined that due to known technological advances and economic conditions, the carrying amount exceeded its fair value. We adjusted the carrying amount of $89,731 to $1,584, and recognized an impairment loss of $88,147 during the year ended December 31, 2012. As of December 31, 2013 and 2012, no amortization has been expensed for the patents, since approval of the patents were pending.


	Fair Value of Financial Instruments
	Disclosures about fair value of financial instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2013, the amounts reported for cash, accrued interest, accrued expenses and other current liabilities, and notes payable approximate fair value because of their short maturities.

	We adopted ASC Topic 820 (originally issued as SFAS 157, “Fair Value Measurements”) as of January 1, 2008 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States, and expands disclosures about fair value measurements.

	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

	· Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
	· Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
	· Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2013 and 2012:

		Total	Level 1	Level 2	Level 3
	December 31, 2013:
	Derivative liability	$2,811,962	-	-	$2,811,962
	Convertible notes payable	492,904	-	-	492,904

	Total liabilities measured at fair value	$3,304,866	-	-	$3,304,866



	December 31, 2012:
	Derivative liability	$753,971	-	-	$753,971
	Convertible notes payable	86,182	-	-	86,182

	Total liabilities measured at fair value	$840,153	-	-	$840,153


	Income (Loss) per Share Calculations
The computation of basic income (loss) per common share is based on the weighted average number of shares outstanding during each year.

The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus the common stock equivalents that would arise from the exercise of stock options and warrants outstanding, using the treasury stock method and the average market price per share during the year. Common stock equivalents are not included in the diluted loss per share calculation when their effect is anti-dilutive.

Since we had no dilutive effect of stock options and warrants for the years ended December 31, 2013 and 2012, our basic weighted average number of common shares outstanding is the same as our diluted weighted average number of common shares outstanding.


Income Taxes
We account for income taxes using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.


Research and Development
Research and development costs are expensed as incurred. Total research and development costs were $439 and $139,706 for the years ended December 31, 2013 and 2012, respectively.


Advertising Costs
We expense the cost of advertising and promotional materials when incurred. We incurred no advertising costs for the years ended December 31, 2013 and 2012.


Stock-Based Compensation
Stock-based compensation is measured at the grant date based on the value of the award granted using the Black-Scholes option pricing model, and recognized over the period in which the award vests. For stock awards no longer expected to vest, any previously recognized stock compensation expense is reversed in the period of termination. The stock-based compensation expense is included in general and administrative expenses.


Comprehensive Loss
Comprehensive loss is the same as net loss for all years presented.


Reclassifications
Certain amounts in the prior years have been reclassified to conform to the current year presentation.


Recently Issued Accounting Pronouncements

No new accounting pronouncements were issued during the year ended December 31, 2013 and through the date of filing this report that we believe are applicable or would have a material impact on our financial statements.

3_Capital_Stock

3. Capital Stock	12 Months Ended
3. Capital Stock	Dec. 31, 2013
Notes	'
3. Capital Stock	'
	3. CAPITAL STOCK

	At December 31, 2013, the Company’s authorized stock consisted of 1,000,000,000 shares of common stock, with $0.001 par value. The Company is also authorized to issue 20,000,000 shares of preferred stock, with a par value of $0.001 per share. The rights, preferences, and privileges of the holders of the preferred stock will be determined by the Board of Directors prior to issuance of such shares.

	During the year ended December 31, 2013, we issued a total of 59,965,470 shares of common stock at fair value in conversion of $219,934 of convertible promissory notes, plus accrued interest payable of $5,517. We recognized a loss of $33,277 on the conversion of the notes. We also issued a total of 592,780 shares of common stock pursuant to a price protection clause in a prior year agreement to issue shares for cash. These shares were recorded at par value.

	During the year ended December 31, 2012, we issued a total of 1,982,113 shares of common stock: 474,721 shares for cash of $253,075; 423,943 for the cashless exercise of warrants recorded at par value; 192,857 shares at fair value for services valued at $166,000; 875,000 shares at fair value for an incentive fee valued at $1,079,800; and 15,592 shares at fair value for accounts payable of $15,705.

4_Stock_Options_Warrants_and_R

4. Stock Options, Warrants and Restricted Stock Awards	12 Months Ended
4. Stock Options, Warrants and Restricted Stock Awards	Dec. 31, 2013
Notes	'
4. Stock Options, Warrants and Restricted Stock Awards	'
	4. STOCK OPTIONS, WARRANTS AND RESTRICTED STOCK AWARDS

	Stock Options

	As of December 31, 2013, our Board of Directors granted a total of 14,100,000 non-qualified stock options to purchase 14,100,000 shares of common stock to our employees, officers and consultants. Stock-based compensation expense included in general and administrative expense was $101,755 and $691,814 for the years ended December 31, 2013 and 2012, respectively.

	In September 2013, the Board of Directors granted a total of 14,000,000 non-qualified stock options to our former chief executive officer and our current chief executive officer to purchase a total of 14,000,000 shares at an exercise price of $0.006 per share. The options vest over a period of 25 months beginning in October 2013 and are exercisable for a period of seven years from the date of grant.

	The estimated grant date fair value of these options was $0.005 per share, and the assumptions used in the Black-Scholes valuation model to determine this estimated fair value are as follows:

	Expected volatility	102.46%
	Expected dividends	0%
	Expected term	7 years
	Risk-free interest rate	2.10%

	As of December 31, 2013, unrecognized stock-based compensation expense was approximately $65,000.

	A summary of the Company’s stock option awards as of December 31, 2013, and changes during the years ended December 31, 2013 and 2012 is as follows:



				Weighted Average
			Weighted	Remaining	Aggregate
			Average	Contract Term	Intrinsic
		Shares	Exercise Price	(Years)	Value

	Outstanding at December 31, 2011	725,000	$3.38
	Granted	762,500	1.45
	Exercised	-	-
	Forfeited or expired	-350,000	2.37

	Outstanding at December 31, 2012	1,137,500	2.39
	Granted	14,000,000	0.006
	Exercised	-	-
	Forfeited or expired	-1,037,500	2.44

	Outstanding at December 31, 2013	14,100,000	$0.02	6.72	$56,000

	Exercisable at December 31, 2013	1,777,500	$0.11	6.65	$6,720

	The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based on our closing stock price of $0.01 as of December 31, 2013, which would have been received by the holders of in-the-money options had the option holders exercised their options as of that date.

	Warrants

	As of December 31, 2013, the Company had 460,000 common stock purchase warrants outstanding, with an exercise price of $0.50 per share and expiring on various dates in 2017 and 2018.

	Restricted Stock Awards

	On September 12, 2013, two consultants were each granted restricted stock awards of 14,000,000 shares of our common stock. The shares vest upon reaching certain defined milestones related to our development and construction of a gas-to-liquid plant. Total compensation deferred at December 31, 2013 to be recognized as the shares vest, calculated using the closing market price of our common stock on the date of grant, was $137,200. No shares had vested at December 31, 2013.

5_Notes_Payable

5. Notes Payable	12 Months Ended
5. Notes Payable	Dec. 31, 2013
Notes	'
5. Notes Payable	'
	5. NOTES PAYABLE

	During the year ended December 31, 2013, the Company issued short-term promissory notes totaling $77,620, $11,000 for cash, $40,470 in payment of accounts payable and $26,150 issued for services. All of these notes were subsequently exchanged for convertible notes payable (Note 6) during the year ended December 31, 2013.

6_Convertible_Notes_Payable

6. Convertible Notes Payable	12 Months Ended
	Dec. 31, 2013
Notes	'
6. Convertible Notes Payable	'
	6. CONVERTIBLE NOTES PAYABLE

	Institutional Lender

	We entered into two securities purchase agreements on September 19, 2012 and December 12, 2012, for the issuance of two 8% convertible promissory notes in the aggregate principal amount of $75,000. The notes were convertible into shares of our common stock at a price equal to a variable conversion price of 58% multiplied by a defined market price, representing a discount of 42%. The market price was defined as the average of the lowest three (3) trading prices for our common stock during a ten trading day period ending on the latest complete trading day prior to the conversion date. Subsequently, during the year ended December 31, 2013 both notes were converted into shares of our common stock, extinguishing a total of $75,000 in principal and $3,000 in accrued interest.

	We subsequently entered into two additional securities purchase agreements with the same lender on July 8, 2013 and September 16, 2013, for the issuance of two 8% promissory notes in the aggregate principal amount of $75,000. One note matures on April 10, 2014, and the other matures on June 18, 2014. The notes are convertible into shares of our common stock at a variable conversion price determined in the same manner as the first two notes described above. We recorded a debt discount of $75,000 related to the conversion feature of the notes, along with a derivative liability at inception. As of December 31, 2013, total amortization was recorded in the amount of $39,629, resulting in a remaining debt discount of $35,371 at December 31, 2013.

	Securities Purchase Agreement - $299,212

	On December 12, 2012, we exchanged certain promissory notes in the aggregate amount of $327,500 for convertible promissory notes. We entered into securities purchase agreements for the sale of 10% convertible promissory notes in the aggregate principal amount of $327,500, which were convertible into shares of our common stock at a conversion price equal to (a) the lesser of $0.54 per share or (b) 50% of the lowest trade price recorded on any trade date after the effective date, or (c) the lowest effective price per share granted to any person after the effective date. The notes were to mature one year from the effective date of the note. We recorded a debt discount of $327,500 related to the conversion feature of the note, along with a derivative liability at inception. During 2013, the principal sum of $62,000, plus accrued interest was transferred to another investor, and a total of $36,057 principal and $886 accrued interest were converted into shares of our common stock. During 2013, the aggregate debt discount balance as of December 31, 2012 of $312,740 was fully amortized to interest expense.

	Effective October 24, 2013, the remaining principal balance of the notes discussed in the preceding paragraph totaling $291,443 and accrued interest of $7,769 were combined in a new 10% convertible promissory note in the aggregate amount of $299,212, which matures on October 24, 2014. The new note is convertible into shares of our common stock at a conversion price equal to (a) the lesser of $0.006 per share or (b) 50% of the lowest trade price recorded on any trade date after the effective date, or (c) the lowest effective price per share granted to any person after the effective date. A total of $16,750 principal and $1,631 accrued interest were subsequently converted into shares of our common stock, resulting in a principal balance of $282,462 payable at December 31, 2013.

	Securities Purchase Agreements - Services of $244,452

	On December 31, 2012, we entered into convertible promissory notes with three individuals in exchange for services rendered in the aggregate amount of $244,452, including $185,852 with the Chairman of our Board of Directors and our former Chief Executive Officer. We entered into securities purchase agreements for the sale of 5% convertible promissory notes in the principal amount of $244,452, which are convertible into shares of our common stock at a conversion price equal to the lesser of $0.20 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The notes mature two years from their effective dates, or December 31, 2014. We recorded a debt discount of $237,742 related to the conversion feature of the notes, along with a derivative liability at inception. During 2013, total amortization was recorded in the amount of $118,993, resulting in a remaining debt discount of $120,958 at December 31, 2013.

	Securities Purchase Agreement - $100,000

	During 2013, we received total proceeds of $40,000 pursuant to a securities purchase agreement for the sale of 10% convertible promissory notes in the aggregate principal amount of $100,000. The notes are convertible into shares of our common stock at a price equal to a variable conversion price of the lesser of $0.09 per share or fifty percent (50%) of the lowest trade price recorded after the effective date. The notes were to mature one year from their effective date. We recorded a debt discount of $40,000 related to the beneficial conversion feature of the notes. During 2013, total amortization was recorded in the amount of $31,151, resulting in a remaining discount of $8,849 at December 31, 2013.

	Securities Purchase Agreement - $335,000

	On October 8, 2012, we received proceeds of $75,000 pursuant to a securities purchase agreement for the sale of 10% convertible promissory notes in aggregate principal amount of $335,000 with a 10% Original Issue Discount (OID) of $35,000. The principal amount of $83,750 outstanding on the note as of December 31, 2012 included the payment of $75,000 plus the unamortized original issue discount of $8,750. We recorded a debt discount of $54,843 related to the conversion feature of the note and $8,750 related to the original issue discount, along with a derivative liability at inception. During 2013, the principal sum of $80,844 was converted into shares of our common stock. The remaining principal balance of $2,906 was transferred to and included in a new note payable to this lender. During 2013, the balance of the debt discount at December 31, 2012 of $43,283 was fully amortized to interest expense.

	On February 27, 2013, we received additional proceeds of $25,000 on this securities purchase agreement, with an original issue discount of $4,313 for total principal owed of $29,313. We recorded a debt discount of $25,403 related to the conversion feature of the note and the original issue discount, along with a derivative liability at inception. During 2013, total amortization was recorded in the amount of $23,266, resulting in a remaining discount of $2,137 at December 31, 2013. If the notes are repaid before 90 days, the interest rate will be zero percent (0%), otherwise a one-time interest rate of five percent (5%) will be applied to the principal sums outstanding. As of December 31, 2013, all interest was owed. The notes are convertible into shares of common stock of the Company at a price equal to the lesser of $0.72 or 70% of the lowest trade price in the 25 trading days prior to the conversion. The notes mature one year from the effective date of each advance.

	On December 10, 2013, we received additional proceeds of $25,000 on this securities purchase agreement, with an original issue discount of $4,312 and the transfer of $2,137 principal and $4,957 accrued interest for total principal owed of $36,406. We recorded a debt discount of $29,312 related to the conversion feature of the note and the original issue discount, along with a derivative liability at inception. During 2013, total amortization was recorded in the amount of $1,686, resulting in a remaining discount of $27,626 at December 31, 2013.

	During 2013, a total of $11,284 principal was converted into shares of our common stock.

	Securities Purchase Agreement – Accounts Payable of $29,500

	On March 14, 2013, we entered into a convertible promissory note in exchange for accounts payable in the amount of $29,500. We entered into securities purchase agreements for the sale of a 5% convertible promissory note in the principal amount of $29,500, which is convertible into shares of our common stock at a conversion price equal to the lesser of $0.15 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The note matures two years from its effective date, or March 14, 2015.

	Securities Purchase Agreement - $97,000

	On May 29, 2013, we exchanged $97,000 in demand promissory notes for convertible promissory notes pursuant to a securities purchase agreement for the sale of a 10% convertible promissory note in the aggregate principal amount of $97,000. The notes are convertible into shares of our common stock at a price equal to a conversion price of the lesser of $0.028 per share or fifty percent (50%) of the lowest trade price recorded after the effective date. The note matures six months from the effective date. We recorded a debt discount of $97,000 related to the beneficial conversion feature of the note. During 2013, the debt discount of $97,000 was fully amortized to interest expense.

	Securities Purchase Agreement – Services of $25,000

	On June 4, 2013, we entered into a convertible promissory note with a member of our Board of Directors in exchange for services rendered in the amount of $25, 000. We entered into securities purchase agreements for the sale of a 5% convertible promissory note in the principal amount of $25,000, which is convertible into shares of common stock of the Company at a conversion price equal to the lesser of $0.035 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The note matures three years from its effective date, or June 4, 2016.

	Securities Purchase Agreement – Chief Executive Officer Services of $15,000

	On May 31, 2013, we entered into a convertible promissory note in exchange for services rendered by our Chief Executive Officer in the amount of $15,000. We entered into securities purchase agreements for the sale of a 5% convertible promissory note in the principal amount of $15,000, which is convertible into shares of our common stock at a conversion price equal to the lesser of $0.04 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The note was to mature two years from its effective date. Subsequently in 2013, the Chief Executive Officer contributed the note to capital.

	Securities Purchase Agreement - $5,000 Exchanged Note

	On September 6, 2013, we exchanged a $5,000 promissory note for a convertible promissory note pursuant to a securities purchase agreement for the sale of a 10% convertible promissory note in the aggregate principal amount of $5,000. The note is convertible into shares of our common stock at a price equal to a conversion price of the lesser of $0.0042 per share or fifty percent (50%) of the lowest trade price recorded after the effective date. The note matures on June 30, 2014. We recorded a debt discount of $2,536 related to the beneficial conversion feature of the note, along with a derivative liability at inception. During 2013, total amortization was recorded in the amount of $1,077, resulting in a remaining discount of $1,459 at December 31, 2013.

	Securities Purchase Agreement - $250,000

	On October 8, 2012, we entered into to a securities purchase agreement for the sale of 10% convertible promissory notes in aggregate principal amount of $250,000. The notes are convertible into shares of common stock of the Company at a price equal to the lesser of $0.006 or 50% of the lowest trade price subsequent to the effective date of the note and prior to the conversion. The notes mature six months from the effective date of each advance.

	The lender previously advanced a total of $11,000 in August and September 2013 that was transferred to this agreement. We recorded a debt discount of $11,000 along with a derivative liability upon transfer. During 2013, total amortization was recorded in the amount of $5,137, resulting in a remaining discount of $5,863 at December 31, 2013.

	On October 21, 2013, we received additional proceeds of $22,000 on this securities purchase agreement. We recorded a debt discount of $22,000 along with a derivative liability at inception. During 2013, total amortization was recorded in the amount of $8,582, resulting in a remaining discount of $13,418 at December 31, 2013.

	On November 22, 2013, we received additional proceeds of $25,000 on this securities purchase agreement. We recorded a debt discount of $25,000 along with a derivative liability at inception. During 2013, total amortization was recorded in the amount of $5,387, resulting in a remaining discount of $19,613 at December 31, 2013.

	For purpose of determining the fair market value of the derivative liability, we used the Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivative liability at December 31, 2013 are as follows:


Stock price on the valuation date	$0.01
Conversion price for the debt	$0.0015 - $0.0076
Dividend yield	0.00%
Years to maturity	0.16 - 1.00
Risk free rate	.13% - .07%
Expected volatility	179.95% - 387.96%

The value of the derivative liability balance at December 31, 2013 was $2,811,962.

The total loss on settlement of debt related to the conversion of notes payable into shares of our common stock was $25,195 for the year ended December 31, 2013.

7_Supplemental_Statement_of_Ca

7. Supplemental Statement of Cash Flows Information	12 Months Ended
7. Supplemental Statement of Cash Flows Information	Dec. 31, 2013
Notes	'
7. Supplemental Statement of Cash Flows Information	'
	7. SUPPLEMENTAL STATEMENT OF CASH FLOWS INFORMATION

	During the years ended December 31, 2013 and 2012, we paid no amounts for income taxes.

	During the years ended December 31, 2013 and 2012, we paid interest of $4,333 and $6,208, respectively.

	During the year ended December 31, 2013, we had the following non-cash investing and financing activities:

	We issued a total of 59,965,470 shares of common stock in conversion of $219,934 in convertible notes payable, plus $5,517 of accrued interest payable, increasing common stock by $59,965, increasing additional paid-in capital by $540,325, decreasing debt discount by $55,942 and decreasing derivative liability by $430,781.

	We exchanged notes payable of $82,620 for convertible notes payable.

	We issued 592,780 shares of common stock pursuant to a price protection clause in a prior year agreement to issue shares for cash, increasing common stock and decreasing additional paid-in capital by $593.

	We increased additional paid-in capital and decreased accrued interest, notes payable by $7,175 to record the contribution of related party accrued interest to capital.

	We increased additional paid-in capital and beneficial conversion feature by $138,951 for the beneficial conversion feature related to new notes and decreased additional paid-in capital by $15,571, increased derivative liability by $6,585 and decreased debt discount by $8,986.

	We issued convertible notes payable for accounts payable of $29,500.

	We issued notes payable for accounts payable of $40,470.

	We decreased convertible notes payable and increased additional paid-in capital by $15,000 for the note contributed to capital.

	We decreased accrued interest payable and increased convertible notes payable by $11,955.

	During the year ended December 2012, we had the following non-cash investing and financing activities:

	We issued 15,592 shares of common stock for payment of accounts payable of $15,705, increasing common stock by $15 and increasing additional paid-in capital by $15,690.

	We issued 423,943 shares of common stock through a cashless exercise of warrants, increasing common stock by $424 and decreasing additional paid-in capital by $424
	.

8_Income_Taxes

8. Income Taxes	12 Months Ended
8. Income Taxes	Dec. 31, 2013
Notes	'
8. Income Taxes	'
	8. INCOME TAXES

	A reconciliation of the income tax provision (benefit) that would result from applying a combined U.S. federal and state rate of 43% to loss before income taxes with the provision (benefit) for income taxes presented in the financial statements is as follows:

		Years Ended December 31,
		2013	2012
	Income tax benefit at statutory rate	($1,503,900)	($1,406,900)
	State income taxes, net of federal benefit	-300	300
	Depreciation	800	8,600
	Research and development	-	4,100
	Loss on disposal of assets	-	28,700
	Non deductible stock deductions	1,335,100	883,700
	Other	36,800	2,300
	Valuation allowance	131,500	479,200

		-	-

	Deferred tax assets (liabilities) are comprised of the following:

		December 31,
		2013	2012

	Deferred tax assets:
	Net operating loss carryforward	$3,204,900	$3,073,800
	Research and development credit carryforward	100,000	100,000
	Related party accrued expenses	4,300	3,300
	Accrued compensated absences	2,400	3,800
	Deferred tax liability:
	Depreciation	-200	-1,000

	Valuation allowance	-3,311,400	-3,179,900

		-	-

	The ultimate realization of our deferred tax assets is dependent, in part, upon the tax laws in effect, our future earnings, and other events. As of December 31, 2013, we recorded a valuation allowance of $3,311,400 against net current deferred tax. In recording the valuation allowance, we were unable to conclude that it is more likely than not that our deferred tax assets will be realized.

	As of December 31, 2013, we had a net operating loss carryforward available to offset future taxable income of approximately $7,453,000, which begins to expire at dates that have not been determined. If substantial changes in the Company’s ownership should occur, there would be an annual limitation of the amount of the net operating loss carryforward that could be utilized.

	We perform a review of our material tax positions in accordance with recognition and measurement standards established by authoritative accounting literature, which requires a company to determine whether it is more likely than not that a tax position will be sustained upon examination based upon the technical merits of the position. If the more-likely-than-not threshold is met, a company must measure the tax position to determine the amount to recognize in the financial statements. Based upon our review and evaluation, during the years ended December 31, 2013 and 2012, we concluded the Company had no unrecognized tax benefit that would affect its effective tax rate if recognized.

	We file income tax returns in the U.S. federal jurisdiction and in the state of California. With few exceptions, we are no longer subject to U.S. federal, state or local income tax examinations by tax authorities for years before 2011.

	We classify any interest and penalties arising from the underpayment of income taxes in our statements of operations and comprehensive loss in other income (expense). As of December 31, 2013 and 2012, we had no accrued interest or penalties related to uncertain tax positions.

9_Related_Party_Transactions

9. Related Party Transactions	12 Months Ended
9. Related Party Transactions	Dec. 31, 2013
Notes	'
9. Related Party Transactions	'
	9. RELATED PARTY TRANSACTIONS

	See Notes 5 and 6 for discussion of notes payable and convertible notes payable with related parties, including many lenders who are also shareholders of the Company.

	On December 12, 2012, we entered into a convertible note with the Chairman of our Board of Directors and our former Chief Executive Officer in exchange for services valued at $185,852. The principal balance of this related party note was $185,852 as of December 31, 2013 and 2012, with accrued interest payable of $9,293 as of December 31, 2013.

	On June 4, 2013, we entered into a convertible note with a member of our Board of Directors in exchange for services valued at $25,000. As of December 31, 2013, the principal balance of this related party note was $25,000, with accrued interest payable of $719.

	On May 31, 2013, we entered into a convertible promissory note in exchange for services rendered by our Chief Executive Officer in the amount of $15,000. Subsequently in 2013, the Chief Executive Officer contributed the note to capital and we decreased convertible notes payable and increased additional paid-in capital by $15,000.

	In 2013, we increased additional paid-in capital and decreased accrued interest, notes payable by $7,175 to record the contribution of related party accrued interest to capital.

10_Operating_Lease

10. Operating Lease	12 Months Ended
10. Operating Lease	Dec. 31, 2013
Notes	'
10. Operating Lease	'
	10. OPERATING LEASE

	We extended our facility lease for a period of five years, expiring on September 30, 2017. The base rent for the period of October 1, 2012 to September 30, 2013 is $2,884 per month, and for the remaining period commencing on October 1, 2013 to September 30, 2017 the base rent will be $2,971 per month. Rent expense for the years ended December 31, 2013 and 2012 was $53,045 and $46,089, respectively.

11_Subsequent_Events

11. Subsequent Events	12 Months Ended
11. Subsequent Events	Dec. 31, 2013
Notes	'
11. Subsequent Events	'
	11. SUBSEQUENT EVENTS

	Management has evaluated subsequent events according to the requirements of ASC TOPIC 855, and has reported the following:

	Subsequent to December 31, 2013, we issued lenders a total of 37,721,757 shares of our common stock in conversion of debt principal of $85,672 and accrued interest of $4,966.

	We received proceeds of $63,000 in January 2014 and $30,000 in February 2014 from convertible promissory notes payable.

2_Summary_of_Significant_Accou1

2. Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Development Stage Activities and Operations	'
	Development Stage Activities and Operations
	The Company is in the development stage of its operations and has had no revenues. A development stage activity is one in which all efforts are devoted substantially to establishing a new business and even if planned principal operations have commenced, revenues are insignificant.
Revenue Recognition	'
	Revenue Recognition
	We will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, we have had no revenues and are in the development stage.
Cash and Cash Equivalent	'
	Cash and Cash Equivalent
	We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, and the fair value of stock options. Actual results could differ from those estimates.
Property and Equipment	'
	Property and Equipment
	Property and equipment are stated at cost, and are depreciated using the straight line method over the following estimated useful lives:

	Computer equipment	3 Years
	Machinery and equipment	7 Years

	During the year ended December 31, 2012, we abandoned equipment in the amount of $155,837, and recognized a loss of $74,078. Depreciation expense for the years ended December 31, 2013 and 2012 was $2,354 and $23,394, respectively.
Patents and Impairment of Long-lived Assets	'
	Patents and Impairment of Long-Lived Assets
	Our intangible assets that have finite lives consist of patents, the cost of which is amortized over the estimated legal life of 15 years. During the year ended December 31, 2012, we reviewed the capitalized costs of patents for impairment and determined that due to known technological advances and economic conditions, the carrying amount exceeded its fair value. We adjusted the carrying amount of $89,731 to $1,584, and recognized an impairment loss of $88,147 during the year ended December 31, 2012. As of December 31, 2013 and 2012, no amortization has been expensed for the patents, since approval of the patents were pending.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	Disclosures about fair value of financial instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2013, the amounts reported for cash, accrued interest, accrued expenses and other current liabilities, and notes payable approximate fair value because of their short maturities.

	We adopted ASC Topic 820 (originally issued as SFAS 157, “Fair Value Measurements”) as of January 1, 2008 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States, and expands disclosures about fair value measurements.

	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

	· Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
	· Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
	· Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2013 and 2012:

		Total	Level 1	Level 2	Level 3
	December 31, 2013:
	Derivative liability	$2,811,962	-	-	$2,811,962
	Convertible notes payable	492,904	-	-	492,904

	Total liabilities measured at fair value	$3,304,866	-	-	$3,304,866



	December 31, 2012:
	Derivative liability	$753,971	-	-	$753,971
	Convertible notes payable	86,182	-	-	86,182

	Total liabilities measured at fair value	$840,153	-	-	$840,153

Income (loss) Per Share Calculations	'
	Income (Loss) per Share Calculations
	The computation of basic income (loss) per common share is based on the weighted average number of shares outstanding during each year.

	The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus the common stock equivalents that would arise from the exercise of stock options and warrants outstanding, using the treasury stock method and the average market price per share during the year. Common stock equivalents are not included in the diluted loss per share calculation when their effect is anti-dilutive.

	Since we had no dilutive effect of stock options and warrants for the years ended December 31, 2013 and 2012, our basic weighted average number of common shares outstanding is the same as our diluted weighted average number of common shares outstanding.
Income Taxes	'
	Income Taxes
	We account for income taxes using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
Research and Development	'
	Research and Development
	Research and development costs are expensed as incurred. Total research and development costs were $439 and $139,706 for the years ended December 31, 2013 and 2012, respectively.
Advertising Costs	'
	Advertising Costs
	We expense the cost of advertising and promotional materials when incurred. We incurred no advertising costs for the years ended December 31, 2013 and 2012.
Stock-based Compensation	'
	Stock-Based Compensation
	Stock-based compensation is measured at the grant date based on the value of the award granted using the Black-Scholes option pricing model, and recognized over the period in which the award vests. For stock awards no longer expected to vest, any previously recognized stock compensation expense is reversed in the period of termination. The stock-based compensation expense is included in general and administrative expenses.
Comprehensive Loss	'
	Comprehensive Loss
	Comprehensive loss is the same as net loss for all years presented.
Reclassifications	'
	Reclassifications
	Certain amounts in the prior years have been reclassified to conform to the current year presentation.
Recently Issued Accounting Pronouncements	'
	Recently Issued Accounting Pronouncements

	No new accounting pronouncements were issued during the year ended December 31, 2013 and through the date of filing this report that we believe are applicable or would have a material impact on our financial statements.

2_Summary_of_Significant_Accou2

2. Summary of Significant Accounting Policies: Fair Value of Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	'

		Total	Level 1	Level 2	Level 3
	December 31, 2013:
	Derivative liability	$2,811,962	-	-	$2,811,962
	Convertible notes payable	492,904	-	-	492,904

	Total liabilities measured at fair value	$3,304,866	-	-	$3,304,866



	December 31, 2012:
	Derivative liability	$753,971	-	-	$753,971
	Convertible notes payable	86,182	-	-	86,182

	Total liabilities measured at fair value	$840,153	-	-	$840,153

4_Stock_Options_Warrants_and_R1

4. Stock Options, Warrants and Restricted Stock Awards: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	'

	Expected volatility	102.46%
	Expected dividends	0%
	Expected term	7 years
	Risk-free interest rate	2.10%

4_Stock_Options_Warrants_and_R2

4. Stock Options, Warrants and Restricted Stock Awards: Schedule Of Share Based Compensation Stock Options Activity (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule Of Share Based Compensation Stock Options Activity	'

				Weighted Average
			Weighted	Remaining	Aggregate
			Average	Contract Term	Intrinsic
		Shares	Exercise Price	(Years)	Value

	Outstanding at December 31, 2011	725,000	$3.38
	Granted	762,500	1.45
	Exercised	-	-
	Forfeited or expired	-350,000	2.37

	Outstanding at December 31, 2012	1,137,500	2.39
	Granted	14,000,000	0.006
	Exercised	-	-
	Forfeited or expired	-1,037,500	2.44

	Outstanding at December 31, 2013	14,100,000	$0.02	6.72	$56,000

	Exercisable at December 31, 2013	1,777,500	$0.11	6.65	$6,720

6_Convertible_Notes_Payable_Fa

6. Convertible Notes Payable: Fair Value Inputs, Liabilities, Quantitative Information (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Fair Value Inputs, Liabilities, Quantitative Information	'


	Stock price on the valuation date	$0.01
	Conversion price for the debt	$0.0015 - $0.0076
	Dividend yield	0.00%
	Years to maturity	0.16 - 1.00
	Risk free rate	.13% - .07%
	Expected volatility	179.95% - 387.96%

8_Income_Taxes_Schedule_of_Com

8. Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Components of Income Tax Expense (Benefit)	'

		Years Ended December 31,
		2013	2012
	Income tax benefit at statutory rate	($1,503,900)	($1,406,900)
	State income taxes, net of federal benefit	-300	300
	Depreciation	800	8,600
	Research and development	-	4,100
	Loss on disposal of assets	-	28,700
	Non deductible stock deductions	1,335,100	883,700
	Other	36,800	2,300
	Valuation allowance	131,500	479,200

		-	-

8_Income_Taxes_Schedule_of_Def

8. Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Deferred Tax Assets and Liabilities	'

		December 31,
		2013	2012

	Deferred tax assets:
	Net operating loss carryforward	$3,204,900	$3,073,800
	Research and development credit carryforward	100,000	100,000
	Related party accrued expenses	4,300	3,300
	Accrued compensated absences	2,400	3,800
	Deferred tax liability:
	Depreciation	-200	-1,000

	Valuation allowance	-3,311,400	-3,179,900

		-	-

1_Organization_and_Line_of_Bus1

1. Organization and Line of Business (Details)	12 Months Ended
1. Organization and Line of Business (Details)	Dec. 31, 2013
Details	'
Entity Incorporation, Date of Incorporation	25-Aug-06

2_Summary_of_Significant_Accou3

2. Summary of Significant Accounting Policies: Property and Equipment (Details) (USD $)	12 Months Ended		88 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Depreciation and amortization	$2,354	$23,394	$111,774
Computer Equipment	'	'	'
Property, Plant and Equipment, Useful Life	'3 years	'	'
Machinery and Equipment	'	'	'
Property, Plant and Equipment, Useful Life	'7 years	'	'
Equipment	'	'	'
Property, Plant and Equipment, Disposals	'	155,837	'
Gain (Loss) on Disposition of Property Plant Equipment	'	($74,078)	'

2_Summary_of_Significant_Accou4

2. Summary of Significant Accounting Policies: Patents and Impairment of Long-lived Assets (Details) (USD $)	12 Months Ended		88 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Details	'	'	'
OTHER ASSETS - Patents	$1,784	$1,584	$1,784
Impairment of intangible assets	'	$88,147	$88,147

2_Summary_of_Significant_Accou5

2. Summary of Significant Accounting Policies: Fair Value of Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Liabilities, Fair Value Disclosure, Recurring	$3,304,866	$840,153
Fair Value, Inputs, Level 1	'	'
Liabilities, Fair Value Disclosure, Recurring	'	'
Fair Value, Inputs, Level 2	'	'
Liabilities, Fair Value Disclosure, Recurring	'	'
Fair Value, Inputs, Level 3	'	'
Liabilities, Fair Value Disclosure, Recurring	3,304,866	840,153
Derivative Financial Instruments, Liabilities	'	'
Liabilities, Fair Value Disclosure, Recurring	2,811,962	753,971
Derivative Financial Instruments, Liabilities \| Fair Value, Inputs, Level 1	'	'
Liabilities, Fair Value Disclosure, Recurring	'	'
Derivative Financial Instruments, Liabilities \| Fair Value, Inputs, Level 2	'	'
Liabilities, Fair Value Disclosure, Recurring	'	'
Derivative Financial Instruments, Liabilities \| Fair Value, Inputs, Level 3	'	'
Liabilities, Fair Value Disclosure, Recurring	2,811,962	753,971
Convertible notes payable	'	'
Liabilities, Fair Value Disclosure, Recurring	492,904	86,182
Convertible notes payable \| Fair Value, Inputs, Level 1	'	'
Liabilities, Fair Value Disclosure, Recurring	'	'
Convertible notes payable \| Fair Value, Inputs, Level 2	'	'
Liabilities, Fair Value Disclosure, Recurring	'	'
Convertible notes payable \| Fair Value, Inputs, Level 3	'	'
Liabilities, Fair Value Disclosure, Recurring	$492,904	$86,182

2_Summary_of_Significant_Accou6

2. Summary of Significant Accounting Policies: Research and Development (Details) (USD $)	12 Months Ended		88 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Details	'	'	'
Research and development	$439	$139,706	$1,245,808

2_Summary_of_Significant_Accou7

2. Summary of Significant Accounting Policies: Advertising Costs (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Advertising Revenue Cost	$0	$0

3_Capital_Stock_Details

3. Capital Stock (Details) (USD $)	4 Months Ended	12 Months Ended						88 Months Ended
3. Capital Stock (Details) (USD $)	Dec. 31, 2006	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2007	Dec. 31, 2013
Common Stock, shares authorized	'	1,000,000,000	1,000,000,000	'	'	'	'	1,000,000,000
Common Stock Par Value	'	$0.00	$0.00	'	'	'	'	$0.00
Preferred Stock, shares authorized	'	20,000,000	20,000,000	'	'	'	'	20,000,000
Preferred Stock Par Value	'	$0.00	$0.00	'	'	'	'	$0.00
Loss on settlement of debt	'	($25,195)	($705)	'	'	'	'	($25,900)
Issuance of common stock pursuant to price protection agreement, shares	'	592,780	'	'	'	'	'	'
Issuance of common stock for cash, shares	'	'	474,721	'	'	'	'	'
Issuance of common stock for cash, value	539,375	'	253,075	1,482,000	826,000	745,000	1,807,500	'
Cashless issuance of common stock warrants, shares	'	'	423,943	'	'	'	'	'
Issuance of common stock for services, shares	'	'	192,857	'	'	'	'	'
Issuance of common stock for services, value	'	'	166,000	'	'	176,038	222,200	'
Issuance of common stock for incentive fee, value	'	'	1,079,800	'	'	'	'	'
Issuance of common stock for acccounts payable, shares	'	'	15,592	'	'	'	'	'
Issuance of common stock for acccounts payable, value	'	'	15,705	'	'	'	'	'
Principal	'	'	'	'	'	'	'	'
Debt Conversion, Original Debt, Amount	'	219,934	'	'	'	'	'	'
Loss on settlement of debt	'	-33,277	'	'	'	'	'	'
Accrued interest	'	'	'	'	'	'	'	'
Debt Conversion, Original Debt, Amount	'	5,517	'	'	'	'	'	'
Common stock	'	'	'	'	'	'	'	'
Debt Conversion, Converted Instrument, Shares Issued	'	59,965,470	'	'	'	'	'	'
Issuance of common stock pursuant to price protection agreement, shares	'	592,780	'	'	'	'	'	'
Total Stock Issued During Period	'	1,982,113	'	'	'	'	'	'
Issuance of common stock for cash, shares	3,211,125	'	474,721	1,141,000	685,715	574,175	448,125	'
Issuance of common stock for cash, value	3,211	'	475	1,141	686	575	448	'
Cashless issuance of common stock warrants, shares	'	'	423,943	3,333,338	'	'	'	'
Issuance of common stock for services, shares	'	'	192,857	'	'	44,009	49,300	'
Issuance of common stock for services, value	'	'	193	'	'	43	50	'
Issuance of common stock for incentive fee, shares	'	'	875,000	'	'	'	'	'
Issuance of common stock for incentive fee, value	'	'	875	'	'	'	'	'
Issuance of common stock for acccounts payable, shares	'	'	15,592	'	'	'	'	'
Issuance of common stock for acccounts payable, value	'	'	$15	'	'	'	'	'

4_Stock_Options_Warrants_and_R3

4. Stock Options, Warrants and Restricted Stock Awards (Details) (USD $)	12 Months Ended			12 Months Ended				1 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2013
	Dec. 31, 2013	Dec. 31, 2012	Employee Stock Option	Restricted Stock	General and Administrative Expense	General and Administrative Expense	Management	Consultants	Consultants
Options, Granted	14,000,000	762,500	'	'	'	'	14,100,000	14,000,000	'
Allocated Share-based Compensation Expense	'	'	'	'	$101,755	$691,814	'	'	'
Options, Granted, Weighted Average Exercise Price	$0.01	$1.45	'	'	'	'	'	$0.01	'
Award Vesting Period	'	'	'	'	'	'	'	'	'25 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$0.01	'	'	'	'	'	'	'	'
Fair Value Assumptions, Method Used	'Black-Scholes valuation model	'	'	'	'	'	'	'	'
Stock Based Compensation Cost Not yet Recognized	'	'	$65,000	$137,200	'	'	'	'	'
Class of Warrant, Outstanding	460,000	'	'	'	'	'	'	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	$0.50	'	'	'	'	'	'	'	'
Non-Option Equity Instruments, Granted	'	'	'	14,000,000	'	'	'	'	'
Equity Instruments Other than Options, Vested in Period	'	'	'	0	'	'	'	'	'

4_Stock_Options_Warrants_and_R4

4. Stock Options, Warrants and Restricted Stock Awards: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	12 Months Ended
	Dec. 31, 2013
Details	'
Expected volatility	102.46%
Expected dividends	0.00%
Expected term	'7 years
Risk-free interest rate	2.10%

4_Stock_Options_Warrants_and_R5

4. Stock Options, Warrants and Restricted Stock Awards: Schedule Of Share Based Compensation Stock Options Activity (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Outstanding, Beginning Balance	1,137,500	725,000
Outstanding, Weighted Average Exercise Price, Beginning Balance	$2.39	$3.38
Granted	14,000,000	762,500
Granted, Weighted Average Exercise Price	$0.01	$1.45
Exercised	'	'
Exercised, Weighted Average Exercise Price	'	'
Forfeited or expired	1,037,500	-350,000
Forfeited or expired, Weighted Average Exercise Price	$2.44	$2.37
Outstanding at December 31, 2012	14,100,000	1,137,500
Outstanding at December 31, 2012, Weighted Average Exercise Price	$0.02	$2.39
Forfeited or expired	-1,037,500	350,000
Outstanding, Ending Balance	14,100,000	1,137,500
Outstanding, Weighted Average Exercise Price, Ending Balance	$0.02	$2.39
Outstanding, Weighted Average Remaining Contractual Term	'6 years 8 months 19 days	'
Outstanding, Aggregate Intrinsic Value	$56,000	'
Exercisable	1,777,500	'
Exercisable, Weighted Average Exercise Price	$0.11	'
Exercisable, Weighted Average Remaining Contract Term	'6 years 7 months 24 days	'
Exercisable, Aggregate Intrinsic Value	$6,720	'

5_Notes_Payable_Details

5. Notes Payable (Details) (Short-term promissory notes, USD $)	Dec. 31, 2013
Debt Instrument, Face Amount	$77,620
Purchased with cash	'
Debt Instrument, Face Amount	11,000
Purchased with accounts payable	'
Debt Instrument, Face Amount	40,470
Issued for services	'
Debt Instrument, Face Amount	$26,150

6_Convertible_Notes_Payable_De

6. Convertible Notes Payable (Details) (USD $)

12 Months Ended

88 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 12, 2012

Dec. 31, 2013

Sep. 16, 2013

Dec. 12, 2012

Dec. 31, 2013

Dec. 12, 2013

Dec. 12, 2012

Dec. 31, 2013

Oct. 24, 2013

Dec. 31, 2013

Oct. 24, 2013

Dec. 31, 2013

Oct. 24, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Oct. 08, 2012

Dec. 31, 2012

Oct. 08, 2012

Dec. 31, 2012

Dec. 31, 2013

Feb. 27, 2013

Dec. 31, 2013

Dec. 10, 2013

Feb. 27, 2013

Dec. 31, 2013

29-May-13

Dec. 31, 2013

Sep. 06, 2013

Dec. 31, 2013

Oct. 08, 2013

Dec. 31, 2013

Oct. 08, 2013

Dec. 31, 2013

Oct. 21, 2013

Dec. 31, 2013

Nov. 22, 2013

Principal

Accrued interest

Convertible Promissory Note

Convertible Promissory Note 1a

Convertible Promissory Note 1b

Convertible Promissory Note 1

Convertible Promissory Note 2

Convertible Promissory Note 3

Convertible Promissory Note 4

Convertible Promissory Note 5

Convertible Promissory Note 6

Convertible Promissory Note 7

Convertible Promissory Note 8

Convertible Promissory Note 9

Convertible Promissory Note 10

Convertible Promissory Note 11

Convertible Promissory Note 12

Convertible Promissory Note 13

Convertible Promissory Note 14

Convertible Promissory Note 15

Principal

Accrued interest

Principal

Accrued interest

Principal

Accrued interest

Board of Directors Chairman

Principal

Accrued interest

Principal

Original issue discount

Unamortized original issue discount

Conversion feature

Principal

Accrued interest

Director

Principal

Accrued interest

Chief Executive Officer

Advance 1

Advance 2

Advance 3

Board of Directors Chairman

Director

Debt Instrument, Interest Rate, Stated Percentage

8.00%

10.00%

5.00%

10.00%

5.00%

10.00%

5.00%

10.00%

Debt Instrument, Face Amount

$75,000

$327,500

$282,462

$299,212

$291,443

$7,769

$244,452

$185,852

$9,293

$100,000

$335,000

$25,000

$29,500

$97,000

$25,000

$719

$15,000

$5,000

$250,000

$11,000

$22,000

$25,000

Debt Instrument, Convertible, Terms of Conversion Feature

'The notes were convertible into shares of our common stock at a price equal to a variable conversion price of 58% multiplied by a defined market price, representing a discount of 42%. The market price was defined as the average of the lowest three (3) trading prices for our common stock during a ten trading day period ending on the latest complete trading day prior to the conversion date.

'which were convertible into shares of our common stock at a conversion price equal to (a) the lesser of $0.54 per share or (b) 50% of the lowest trade price recorded on any trade date after the effective date, or (c) the lowest effective price per share granted to any person after the effective date.

'The new note is convertible into shares of our common stock at a conversion price equal to (a) the lesser of $0.006 per share or (b) 50% of the lowest trade price recorded on any trade date after the effective date, or (c) the lowest effective price per share granted to any person after the effective date.

'convertible into shares of our common stock at a conversion price equal to the lesser of $0.20 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion.

'The notes are convertible into shares of our common stock at a price equal to a variable conversion price of the lesser of $0.09 per share or fifty percent (50%) of the lowest trade price recorded after the effective date.

'If the notes are repaid before 90 days, the interest rate will be zero percent (0%), otherwise a one-time interest rate of five percent (5%) will be applied to the principal sums outstanding. As of December 31, 2013, all interest was owed. The notes are convertible into shares of common stock of the Company at a price equal to the lesser of $0.72 or 70% of the lowest trade price in the 25 trading days prior to the conversion.

'convertible into shares of our common stock at a conversion price equal to the lesser of $0.15 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion

'The notes are convertible into shares of our common stock at a price equal to a conversion price of the lesser of $0.028 per share or fifty percent (50%) of the lowest trade price recorded after the effective date.

'convertible into shares of common stock of the Company at a conversion price equal to the lesser of $0.035 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion.

'convertible into shares of our common stock at a conversion price equal to the lesser of $0.04 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion.

'The note is convertible into shares of our common stock at a price equal to a conversion price of the lesser of $0.0042 per share or fifty percent (50%) of the lowest trade price recorded after the effective date.

'convertible into shares of common stock of the Company at a price equal to the lesser of $0.006 or 50% of the lowest trade price subsequent to the effective date of the note and prior to the conversion

Debt Conversion, Original Debt, Amount

219,934

5,517

75,000

3,000

36,057

886

16,750

1,631

80,844

11,284

Debt Instrument, Maturity Date

10-Apr-14

18-Jun-14

31-Dec-14

14-Mar-15

4-Jun-16

30-Jun-14

Convertible promissory notes discount

226,445

644,520

226,445

35,371

75,000

327,500

120,958

237,742

8,849

40,000

8,750

54,843

2,137

25,403

27,626

29,312

97,000

1,459

2,536

5,863

11,000

13,418

22,000

19,613

25,000

Amortization of debt discount and beneficial conversion feature recorded to interest expense

694,795

44,942

739,737

39,629

312,740

118,993

31,151

43,283

23,266

1,686

97,000

1,077

5,137

8,582

5,387

Amount transferred to another investor

62,000

2,906

2,137

4,957

Proceeds from notes payable

11,000

636,000

40,000

75,000

25,000

Original issue discount percent

10.00%

Original issue discount

35,000

4,313

4,312

Long-term Debt, Gross

83,750

75,000

8,750

29,313

36,406

Derivative liability

2,811,962

753,971

2,811,962

Loss on settlement of debt

($25,195)

($705)

($25,900)

($33,277)

6_Convertible_Notes_Payable_Fa1

6. Convertible Notes Payable: Fair Value Inputs, Liabilities, Quantitative Information (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Stock price on the valuation dates	$0.01
Dividend yield	0.00%
Minimum	'
Conversion price for the debt	$0.00
Years to maturity	'1 month 28 days
Risk free rate	0.13%
Expected volatility	179.95%
Maximum	'
Conversion price for the debt	$0.01
Years to maturity	'1 year
Risk free rate	0.07%
Expected volatility	387.96%

7_Supplemental_Statement_of_Ca1

7. Supplemental Statement of Cash Flows Information (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Income Taxes Paid	$0	$0
Interest Paid	$4,333	$6,208

7_Supplemental_Statement_of_Ca2

7. Supplemental Statement of Cash Flows Information: Non-cash investing and financing activities, 2013 (Details) (USD $)	12 Months Ended	88 Months Ended
	Dec. 31, 2013	Dec. 31, 2013
Issuance of common stock for conversion of debt, value	$600,290	'
Increase Decrease in Debt Discount for the Period	-55,942	'
Issuance of common stock pursuant to price protection agreement, shares	592,780	'
Contribution of accrued interest to capital	7,175	'
Increase (Decrease) in Interest Payable, Net	-11,955	'
Notes payable issued for services	-66,150	-66,150
Contribution of related party accrued interest to capital	'	'
Contribution of accrued interest to capital	7,175	'
Increase (Decrease) in Interest Payable, Net	-7,175	'
Issuance of New Notes During Period	'	'
Increase Decrease in Debt Discount for the Period	-8,986	'
Increase (Decrease) in Derivative Liabilities	6,585	'
Increase or (decrease) during the reporting period in additional paid in capital in relation to beneficial conversion features.	138,951	'
Increase (decrease) during the reporting period of additional paid in capital	-15,571	'
Note Contributed to Capital	'	'
Increase (decrease) during the reporting period of additional paid in capital	15,000	'
Debt Instrument, Increase (Decrease), Net	15,000	'
Convertible notes payable	'	'
Increase (Decrease) in Notes Payable, Current	11,955	'
Principal	'	'
Debt Conversion, Original Debt, Amount	219,934	'
Increase (Decrease) in Derivative Liabilities	-430,781	'
Accrued interest	'	'
Debt Conversion, Original Debt, Amount	5,517	'
Exchanged for convertible notes payable	'	'
Amount transferred to another investor	82,620	'
Exchange for Accounts Payable 1	'	'
Notes payable issued for services	29,500	'
Exchange for Accounts Payable 2	'	'
Notes payable issued for services	40,470	'
Common stock	'	'
Issuance of common stock for conversion of debt, shares	59,965,470	'
Issuance of common stock for conversion of debt, value	59,965	'
Issuance of common stock pursuant to price protection agreement, shares	592,780	'
Issuance of common stock pursuant to price protection agreement, value	593	'
Additional Paid-in Capital	'	'
Issuance of common stock for conversion of debt, value	540,325	'
Issuance of common stock pursuant to price protection agreement, value	-593	'
Contribution of accrued interest to capital	$7,175	'

7_Supplemental_Statement_of_Ca3

7. Supplemental Statement of Cash Flows Information: Non-cash investing and financing activities, 2012 (Details) (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Issuance of common stock for acccounts payable, shares	15,592	'
Issuance of common stock for acccounts payable, value	$15,705	'
Cashless issuance of common stock warrants, shares	423,943	'
Common stock	'	'
Issuance of common stock for acccounts payable, shares	15,592	'
Issuance of common stock for acccounts payable, value	15	'
Cashless issuance of common stock warrants, shares	423,943	3,333,338
Cashless issuance of common stock warrants, value	424	3,334
Additional Paid-in Capital	'	'
Issuance of common stock for acccounts payable, value	15,690	'
Cashless issuance of common stock warrants, value	($424)	($3,334)

8_Income_Taxes_Details

8. Income Taxes (Details) (USD $)	12 Months Ended
8. Income Taxes (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	43.00%	'
Operating Loss Carryforwards	$7,453,000	'
Unrecognized Tax Benefits	0	0
Income Tax Examination, Penalties and Interest Expense	$0	$0

8_Income_Taxes_Schedule_of_Com1

8. Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Details) (USD $)	12 Months Ended		88 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Details	'	'	'
Income tax benefit at statutory rate	($1,503,900)	($1,406,900)	'
State income taxes, net of federal benefit	-300	300	'
Depreciation	800	8,600	'
Research and development	'	4,100	'
Loss on disposal of assets	'	28,700	'
Nondeductible stock deductions	1,335,100	883,700	'
Other	36,800	2,300	'
Valuation allowance	131,500	479,200	'
Income Tax Expense (Benefit), Total	'	'	'

8_Income_Taxes_Schedule_of_Def1

8. Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets:	'	'
Net operating loss carryforward	$3,204,900	$3,073,800
Research and development credit carryforward	100,000	100,000
Related party accrued expenses	4,300	3,300
Accrued compensated absences	2,400	3,800
Deferred tax liability:	'	'
Depreciation	-200	-1,000
Valuation allowance	-3,311,400	-3,179,900
Deferred Tax Assets, Net, Total	'	'

9_Related_Party_Transactions_D

9. Related Party Transactions (Details) (USD $)	12 Months Ended									12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
		Convertible Promissory Note 5	Convertible Promissory Note 5	Convertible Promissory Note 5	Convertible Promissory Note 5	Convertible Promissory Note 12	Convertible Promissory Note 12	Convertible Promissory Note 12	Convertible Promissory Note 13	Note Contributed to Capital	Contribution of related party accrued interest to capital
			Board of Directors Chairman	Board of Directors Chairman	Board of Directors Chairman	Director	Director	Director	Chief Executive Officer
				Principal	Accrued interest		Principal	Accrued interest
Debt Instrument, Face Amount	'	$244,452	$185,852	$185,852	$9,293	$25,000	$25,000	$719	$15,000	'	'
Increase (decrease) during the reporting period of additional paid in capital	'	'	'	'	'	'	'	'	'	15,000	'
Debt Instrument, Increase (Decrease), Net	'	'	'	'	'	'	'	'	'	15,000	'
Contribution of accrued interest to capital	7,175	'	'	'	'	'	'	'	'	'	7,175
Increase (Decrease) in Interest Payable, Net	($11,955)	'	'	'	'	'	'	'	'	'	($7,175)

10_Operating_Lease_Details

10. Operating Lease (Details) (USD $)	12 Months Ended
10. Operating Lease (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Lease Expiration Date	30-Sep-17	'
Operating Leases, Rent Expense	$53,045	$46,089
October 1, 2012 to September 30, 2013	'	'
Operating Lease Monthly Payment Amount	2,884	'
October 1, 2013 to September 30, 2017	'	'
Operating Lease Monthly Payment Amount	$2,971	'

11_Subsequent_Events_Details

11. Subsequent Events (Details) (USD $)	12 Months Ended		88 Months Ended	1 Months Ended		2 Months Ended	3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Feb. 28, 2014	Jan. 31, 2014	Feb. 28, 2014	Mar. 31, 2014
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event
Debt Conversion, Converted Instrument, Shares Issued	'	'	'	'	'	'	37,721,757
Conversion of debt principal	'	'	'	'	'	$85,672	'
Conversion of debt accrued interest	'	'	'	'	'	4,966	'
Proceeds from convertible notes payable	$242,380	$417,500	$634,880	$30,000	$63,000	'	'